Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure-Reference-Cited by-同舟云学术

Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure

Published:2001-08 Issue:10 Volume:15 Page:1718-1726
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

SENZAKI HIDEAKI¹,SMITH CAROLYN J.²,JUANG GEORGE J.¹,ISODA TAKAYOSHI¹,MAYER SHARON P.²,OHLER ANDREAS¹,PAOLOCCI NAZARENO¹,TOMASELLI GORDON F.¹,HARE JOSHUA M.¹,KASS DAVID A.¹

Affiliation:

1. Division of CardiologyDepartment of MedicineJohns Hopkins Medical InstitutionsBaltimoreMaryland21287USA

2. Department of PathologyNew York Medical CollegeValhallaNew YorkUSA

Funder

Institut National de la Santé et de la Recherche Médicale

American Heart Association

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.00-0538com

Reference47 articles.

1. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

2. Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

3. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.

4. Exploring the role of the beta-adrenergic receptor kinase in cardiac disease using gene-targeted mice;Koch W. J.;Trends Cardiovasc. Med.,1999

5. 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure;Heart Failure Reviews;2024-03-18

2. Phosphodiesterases in heart and vessels- From Physiology to Diseases;Physiological Reviews;2023-11-16

3. Investigation of shared genes and regulatory mechanisms associated with coronavirus disease 2019 and ischemic stroke;Frontiers in Neurology;2023-04-05

4. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure;Nature Reviews Cardiology;2022-09-01

5. Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts;International Journal of Molecular Sciences;2022-02-15